Citadel Advisors reported a 4.9% stake in Pliant Therapeutics PLRX · 3,037,695 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 4.9%
Last report: 4.9% · filed 26/01/22
Shares held: 3,037,695 sh
Class: Common Stock, par value $0.0001 per share (the "Shares")
Stock: Pliant Therapeutics PLRX
Holder: Citadel Advisors
Event date: 26/01/23
Filed: 26/01/30

4.9% stake · below 5%

Stake: 4.9%
Last report: 4.9%
Since last report: +0.0pp

Pliant Therapeutics trades, last 26 weeks

What else happened in Pliant Therapeutics around then

Filed or reported within 30 days of the trade day · 25/12/24~02/22

Citadel Advisors's other 5% stake reports

Citadel Advisors
5% stakeVenu Holding
5% stake
Venu Holding
VENU
3.8% stake
2,365,505 sh
3.8% stake
Filed 08/14
Citadel Advisors
5% stakeSpruce Biosciences
5% stake
Spruce Biosciences
SPRB
1.9% stake
51,919 sh
1.9% stake
Filed 08/14
Citadel Advisors
5% stakeMomentus
5% stake
Momentus
MNTS
1.6% stake
309,865 sh
1.6% stake
Filed 08/14
Citadel Advisors
5% stakeXCHG
5% stake
XCHG
XCH
9.7% stake
272,656,440 sh
9.7% stake
Filed 08/14
Citadel Advisors
5% stakeVillage Farms International
5% stake
Village Farms International
VFF
5.5% stake
6,689,240 sh
5.5% stake
Filed 08/14